Endovascular system with circumferentially-overlapping stent-grafts

Information

  • Patent Grant
  • 8951298
  • Patent Number
    8,951,298
  • Date Filed
    Tuesday, June 19, 2012
    12 years ago
  • Date Issued
    Tuesday, February 10, 2015
    10 years ago
  • Inventors
  • Original Assignees
  • Examiners
    • Erezo; Darwin
    • Kapoor; Sidharth
    Agents
    • Sughrue Mion, PLLC
Abstract
A multi-component endovascular stent-graft system (10) includes a body portion (16), which includes a plurality of stent-grafts (20), which include: (a) respective stent members (22), which are shaped, when the stent-grafts (20) are in respective radially-expanded states, so as to define respective tubes, each of which is circumferentially complete at at least one longitudinal location therealong; and (b) respective graft members (24), which circumscribe respective circumferential arcs (40) of the respective stent members (22). The circumferential arcs (40) have respective extents that are less than entire circumferences of the respective stent members (22) at least partially along respective axial lengths of the stent members (22).
Description
FIELD OF THE APPLICATION

This present application relates generally to prostheses and surgical methods, and specifically to tubular prostheses, including endovascular grafts and stent-grafts, and surgical techniques for using the prostheses to maintain patency of body passages such as blood vessels, and treating aneurysms.


BACKGROUND OF THE APPLICATION

Endovascular prostheses are sometimes used to treat aortic aneurysms. Such treatment includes implanting a stent or stent-graft within the diseased vessel to bypass the anomaly. An aneurysm is a sac formed by the dilation of the wall of the artery. Aneurysms may be congenital, but are usually caused by disease or, occasionally, by trauma. Aortic aneurysms which commonly form between the renal arteries and the iliac arteries are referred to as abdominal aortic aneurysms (“AAAs”). Other aneurysms occur in the aorta, such as thoracic aortic aneurysms (“TAAs”) and aortic uni-iliac (“AUI”) aneurysms. A TAA may occur downstream the aortic arch, i.e., in the descending aorta. Alternatively, a TAA may occur in the aortic arch itself, where the aorta branches to supply the brachiocephalic, left carotid and subclavian arteries, or may occur in the ascending aorta.


Endo-Vascular Aneurysm Repair (EVAR) has transformed the practice of treatment of aortic aneurysms from an open surgical approach to a much less invasive surgical approach. The first step of an endovascular intervention usually requires introducing a delivery system into the vasculature of a subject. If the crossing profile, i.e., the external diameter, of the delivery system is 14 Fr or lower (3 Fr=1 millimeter), a true percutaneous approach may be used, because vascular closure devices are available for proper closure of such puncture sites. If the crossing profile at least 15-16 Fr, a vascular cut-down is usually required in advance as a preparatory step to introduction of the delivery system.


Endovascular systems for treatment of supra-renal aneurysms generally require the preparatory step of a vascular cut-down. A cut-down is the localized surgical exposure of blood vessels for accessing the subject's vasculature. For example, most surgical cut-downs used in EVAR procedures are performed in the vicinity of the pubis, exposing the iliac arteries. Surgical cut-downs have related complications and co-morbidities, including difficulty in controlling bleeding at the access site, false aneurysms, and vascular obstruction. It is therefore desirable to use a purely percutaneous approach, instead of a vascular cut-down.


Endovascular stent-grafts for treating the thoracic aorta usually require a 20-22 Fr delivery system, because of the large amount of graft material indicated by the diameter of the aorta above the level of the renal arteries (30-40 mm diameter or more in some subjects). Currently used graft materials are PET (Poly Ethylene Therephtalate) and ePTFE (expanded Poly-Tetra-Fluoro-Ethylene). The thickness and circumferential length of the graft have the most substantial effect on the crossing profile of an endovascular system. The use of thinner graft materials generally reduces long-term durability of the graft material.


SUMMARY OF APPLICATIONS

In some applications of the present invention, a multi-component endovascular stent-graft system has a body portion that comprises a plurality of stent-grafts. The stent-grafts are configured to be assembled in situ in a blood vessel of a subject to define a circumferentially-complete fluid flow path. The stent-grafts comprise respective stent members, which are shaped so as to define respective circumferentially-complete tubes when the stent-grafts are in respective radially-expanded states. The stent-grafts further comprise respective graft members that are securely fixed to the stent members, respectively. The graft members circumscribe respective circumferential arcs of the respective stent members, which circumferential arcs have respective extents that are less than entire circumferences of the respective stent members at least partially along respective axial lengths of the stent members. The graft members collectively cover an entire circumference of the body portion along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. Typically, in order to provide good circumferential sealing between circumferentially-adjacent stent-grafts, pairs of circumferentially-adjacent graft members have respective circumferential overlaps having respective arc extents.


Because each of the stent-grafts comprises substantially less graft and stent material than a typical single-component full-circumference stent-graft, the stent-grafts typically have relatively small crossing profiles. The stent-grafts thus can typically be deployed using catheters having a diameter of no more than 14 Fr. This generally enables the use of a true percutaneous surgical technique, without the need for a vascular cut-down. In addition, because each of the stent members defines a circumferentially-complete tube (at least one point along the length of each stent-graft), upon deployment the stent-grafts are tightly coupled to one another, and form tight blood-impervious seals with one another. Furthermore, if the stent-grafts did not define circumferentially-complete tubes, the stent-grafts might have a tendency to flatten upon deployment.


For some applications, the stent-graft system is deployed in the aorta for treating an aneurysm. During an implementation procedure, a first one of the stent-grafts is transvascularly (typically percutaneously) introduced into the aorta via one of the iliac arteries, while the stent-graft is positioned in a delivery catheter, restrained in its radially-compressed state by the catheter. After being positioned at a desired location in the aorta, the first stein-graft is deployed from the catheter, and assumes its radially-expanded state. A second one of the stent-grafts, while restrained in its radially-compressed state in a catheter, is advanced through the previously-deployed first stent-graft, until the second stent-graft is positioned at least partially (typically, entirely) within the first stent-graft, generally axially aligned with the first stent-graft. Before it is deployed from delivery catheter, the second stent-graft is properly rotationally aligned with the previously-deployed first stent-graft, such that the respective graft members of the stent-grafts will together form a circumferentially-complete fluid flow guide upon full deployment of the second stent-graft (and the other remaining stent-grafts, if any). The second stent-graft is then deployed from the catheter, thereby nesting the second stent-graft within the first stent-graft. For configurations in which the stent-graft system comprises more than two stent-grafts, the procedure described above is repeated for the additional stent-grafts, until the stein-grafts are all deployed to together form the stent-graft system. As a result, the stent-graft system has been assembled in situ to form a circumferentially complete fluid flow guide comprising all of the stent-grafts.


There is therefore provided, in accordance with an application of the present invention, apparatus including a multi-component endovascular stent-graft system, which has proximal and distal ends, and a body portion disposed along at least a part of the stent-graft system longitudinally between the proximal and distal ends, which body portion has an axial length and includes a plurality of stent-grafts, which (a) are configured to assume respective radially-compressed states for transluminal delivery, and respective radially-expanded states for intraluminal fixation, and (b) include:

    • respective stent members, which are shaped, when the stent-grafts are in their respective radially-expanded states, so as to define respective tubes, each of which is circumferentially-complete at least one longitudinal location therealong; and
    • respective graft members, which respectively include one or more biologically-compatible substantially blood-impervious flexible sheets, and which are securely fixed to the stent members, respectively, such that the graft members circumscribe respective circumferential arcs of the respective stent members, which circumferential arcs have respective extents that are less than entire circumferences of the respective stent members at least partially along respective axial lengths of the stent members, when the stent-grafts are in their respective radially-expanded states,


wherein the graft members collectively cover an entire circumference of the body portion along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.


For some applications, the graft members are securely fixed to the stent members, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along at least 80% of the respective axial lengths of the stent members, when the stent-grafts are in their radially-expanded states. For some applications, the graft members are securely fixed to the stent members, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along the entire respective axial lengths of the stent members, when the stent-grafts are in their radially-expanded states.


For some applications, the circumferential arcs have respective arc extents, at least one of which is between 1.1π (pi) and 1.4π (pi) radians. For some applications, each of the respective arc extents is between 1.1π (pi) and 1.4π (pi) radians. For some applications, the stent-graft system includes exactly two stent-grafts.


For some applications, the circumferential arcs have respective arc extents, at least one of which is between 0.75π (pi) and 1.1π (pi) radians. For some applications, each of the respective arc extents is between 0.75π (pi) and 1.1π (pi) radians. For some applications, the stent-graft system includes exactly three stent-grafts.


For some applications, the circumferential arcs have respective arc extents, at least one of which is between 0.6π (pi) and 0.75π (pi) radians. For some applications, each of the respective arc extents is between 0.67π (pi) and 0.752π (pi) radians. For some applications, the stent-graft system includes exactly four stent-grafts.


For some applications, pairs of circumferentially-adjacent graft members have respective circumferential overlaps having respective arc extents, each of which is at least 0.05π (pi) radians, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, each of the overlaps is at least 0.1π (pi) radians. For some applications, the circumferential arcs have respective arc extents, a sum of which is greater than 2.2π (pi) radians, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, the sum is equal to at least 2.6π (pi) radians. For some applications, the sum is equal at least (a) 2π (pi) plus (b) a product of (i) a number of the stent-grafts and (ii) 0.1π (pi) radians.


For any of the applications described above, the circumferential arcs may have respective arc angular centers, which are positioned at respective substantially constant circumferential locations along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (h) the stent-grafts are in their respective radially-expanded states.


For any of the applications described above, the circumferential arcs may have respective arc angular centers, which are positioned at respective circumferential locations that vary along at least a portion of the axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, the respective circumferential locations vary along the entire axial length of the body portion when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, the circumferential arcs have respective arc extents, which are generally constant along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.


For any of the applications described above, the circumferential arcs may have respective arc extents, which vary along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.


For any of the applications described above, the stent-graft system may be shaped so as to define a side-facing fenestration, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, the side-facing fenestration is generally circular. For some applications, a perimeter of the fenestration is between 10% and 50% of a perimeter of the stent-graft system adjacent the fenestration.


For any of the applications described above, the body portion may be disposed along only part of the stent-graft system.


For any of the applications described above, the stent members may be self-expanding.


For any of the applications described above, the stent members may include a superelastic metallic alloy. Alternatively or additionally, for any of the applications described above, the stent members may include a shape memory metallic alloy. Alternatively or additionally, for any of the applications described above, the stent members may include Nitinol.


For any of the applications described above, the stent-graft system may further include a plurality of outwardly protruding fixation elements. For some applications, the fixation elements are positioned at the proximal end of the stent-graft system. For some applications, the fixation elements include barbs.


For any of the applications described above, each of the stent-grafts may further include one or more radiopaque markers.


For any of the applications described above, each of the tubes respectively defined by the stent members may be circumferentially-complete along at least three longitudinal locations thereof.


For any of the applications described above, the apparatus may further include a plurality of delivery catheters, in which the stent-grafts are respectively initially positioned in their radially-compressed states.


There is further provided, in accordance with an application of the present invention, a method including:

    • (i) providing a multi-component endovascular stent-graft system, which has proximal and distal ends, and a body portion disposed along at least a part of the stent-graft system longitudinally between the proximal and distal ends, which body portion has an axial length and includes a plurality of stent-grafts, which (a) are configured to assume respective radially-compressed states for transluminal delivery, and respective radially-expanded states for intraluminal fixation, and (b) include (x) respective stent members, which are shaped so as to define respective circumferentially-complete tubes when the stent-grafts are in their respective radially-expanded states, and (y) respective graft members, which respectively include one or more biologically-compatible substantially blood-impervious flexible sheets, and which are securely fixed to the stent members, respectively, such that the graft members circumscribe respective circumferential arcs of the respective stent members, which circumferential arcs have respective extents that are less than entire circumferences of the respective stent members at least partially along respective axial lengths of the stent members, when the stent-grafts are in their respective radially-expanded states;
    • (ii) transvascularly introducing a first one of the stent-grafts into a blood vessel of a human subject, while the stent-graft is restrained in its radially-compressed state;
    • (iii) thereafter, deploying the first stent-graft in the blood vessel so that the first stent-graft assumes its radially-expanded state;
    • (iv) thereafter, introducing another one of the stent-grafts into the blood vessel and at least partially into the first stent-graft and any of the other stent-grafts already deployed, while the another stent-graft is restrained in its radially-compressed state;
    • (v) thereafter, axially and rotationally orienting the another stent-graft with the first stent-graft and any of the other stent-grafts already deployed, and deploying the another stent-graft in the blood vessel so that the another stent-graft assumes its radially-expanded state; and
    • (vi) thereafter, repeating steps (iv) and (v) until all of the stent-grafts have been deployed in the blood vessel,


wherein deploying the stent-grafts includes deploying the stent-grafts such that the graft members collectively cover an entire circumference of the body portion along the entire axial length of the body portion.


For some applications, deploying the stent-grafts includes deploying the stent-grafts such that pairs of circumferentially-adjacent graft members have respective circumferential overlaps having respective arc extents, each of which is at least 0.05π (pi) radians, such as at least 0.1π (pi) radians.


For some applications, providing the stent-graft system includes providing the stent-graft system in which each of the tubes respectively defined by the stent members is circumferentially-complete along an entire length thereof.


For some applications, the blood vessel is an aorta, and deploying the stent-grafts includes deploying the stent-grafts in the aorta.


For some applications, the method further includes identifying the subject as suffering from an aortic aneurysm, and deploying the stent-grafts includes deploying the stent-grafts responsively to the identifying.


The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A-B are schematic illustrations of a multi-component endovascular stent-graft system, disassembled and assembled, respectively, in accordance with an application of the present invention;



FIG. 2 is a schematic illustration of the stent-graft system of FIGS. 1A-B viewed from a distal end thereof, in accordance with an application of the present invention;



FIGS. 3A-B are schematic illustrations of another configuration of the multi-component endovascular stent-graft system of FIGS. 1A-B and 2, disassembled and assembled, respectively, in accordance with an application of the present invention;



FIGS. 4A-F are schematic illustrations of an exemplary method of deploying the multi-component endovascular stent-graft system of FIGS. 1A-B, 2, and/or 3 in the vicinity of an abdominal aortic aneurysm, in accordance with an application of the present invention;



FIG. 5 is a schematic illustration of another configuration of the stent-graft system of FIGS. 1A-B, in accordance with an application of the present invention; and



FIG. 6 is a schematic illustration of yet another configuration of the stent-graft system of FIGS. 1A-B, in accordance with an application of the present invention.





DETAILED DESCRIPTION OF APPLICATIONS


FIGS. 1A-B are schematic illustrations of a multi-component endovascular stent-graft system 10, in accordance with an application of the present invention. FIGS. 1A and 1B show the stent-graft system disassembled and assembled, respectively. Stent-graft system 10 has proximal and distal ends 12 and 14, and a body portion 16 disposed along at least a part of the stent-graft system longitudinally between proximal and distal ends 12 and 14. Body portion 16 has an axial length L (labeled in FIG. 1B). For some applications, body portion 16 extends along the entire axial length of stent-graft system 10, as shown in the figures. For other applications, the body portion extends along only part of the length of the stent-graft system, such as described hereinbelow with reference to FIG. 6.


Body portion 16 comprises a plurality of stent-grafts 20. In the exemplary configuration shown in FIGS. 1A-B, body portion 16 comprises exactly two stent-grafts 20A and 20B. Each of endovascular stent-grafts 20 is configured to initially be positioned in a delivery catheter in a radially-compressed state for transluminal delivery, such as described hereinbelow with reference to FIGS. 4A and 4C-E, and to assume a radially-expanded state upon being deployed from the delivery catheter for intraluminal fixation, such as described hereinbelow with reference to FIGS. 4B and 4F. FIGS. 1A-B show the endovascular stent-grafts in their respective radially-expanded states. For some applications, the stent-grafts are heat-set to assume the radially-expanded state.


Stent-graft system 10 is assembled in situ by nesting stent-grafts 20 within one another, as shown in FIG. 1B. The stent-grafts are typically sized such that they become tightly coupled to one another upon radial expansion, such as by radial force and/or coupling elements disposed thereupon (e.g., internally connecting barbs) or by an external device (e.g., stapler pins that connect the stent-grafts and that are applied by an independent stapling instrument). It is noted that for applications in which stent-graft system 10 comprises exactly two stent-grafts 20, one of the stent-grafts is nested within the other stent-graft. For applications in which the stent-graft system comprises exactly three stent-grafts, a first one of the stent-grafts is nested within a second one of the stent-grafts, and a third one of the stent-grafts is nested within both the first and second stent-grafts. The stent-grafts of stent-grafts systems comprising more than three stent-grafts are similarly nested within one another.


For some applications, proximal and/or distal portions of the stent-graft system extend proximally and/or distally beyond the body portion comprise anchoring elements, for example as described hereinbelow with reference to FIG. 6, and/or as described in PCT Publication WO 2010/150208, mutatis mutandis, which is incorporated herein by reference, e.g., with reference to FIGS. 3, 7A-C, 9A-B, 10A-B, 13, 15A-C, 16, 17, 18, 19, 20A-B, and/or 21A-B thereof. These proximally- and/or distally-extending portions may be components of all of stent-grafts 20, or of only a portion of stent-grafts 20, such as of only one of stent-grafts 20.


Each of stent-grafts 20 comprises a stent member 22 and a graft member 24. Stent member 22 comprises a plurality of structural stent elements (struts) 26, which, for some applications, are arranged as a plurality of circumferential bands 28. For some applications, at least some of, e.g., all of, the structural stent elements are interconnected, while for other applications, at least a portion of, e.g., all, of the structural stent elements are not interconnected. In the configuration shown in FIGS. 1A-B, circumferential bands 28 are not directly connected to one another, but instead are indirectly connected by graft member 24, to form stent-graft 20. When the stent-grafts are in their respective radially-expanded states, as shown in FIGS. 1A-B, stent members 22 are shaped so as to define respective tubes, each of which is circumferentially-complete at least one longitudinal location therealong, such as along at least 2, at least 3, at least 4, at least 5, or at least 10 longitudinal locations therealong, or an entire length thereof. For some applications in which structural stent elements 26 are arranged as circumferential bands 28, the number of longitudinal locations therealong equals the number of bands 28, as shown in FIGS. 1A-B, 3A-B, and 4A-F. As used in the present application, including in the claims, a “tube” is an elongated hollow object that defines a conduit therethrough. A “tube” may have varied cross-sections therealong, and the cross-sections are not necessarily circular. For example, one or more of the cross-sections may be generally elliptical but not circular, or circular.


Typically, stent members 22 are self-expanding. For some applications, stent members 22 comprise a superelastic metallic alloy, a shape memory metallic alloy, and/or Nitinol.


Each of graft members 24 comprises one or more biologically-compatible substantially blood-impervious flexible sheets, which are securely fixed to stent member 22, either outside or within the stent member, such as by stitching, and covers either an external or an internal surface of a portion of the stent member. The flexible sheet may comprise, for example, a polymeric film material (e.g., polytetrafluoroethylene), a polymeric textile material (e.g., woven polyethylene terephthalate (PET)), natural tissue graft (e.g., saphenous vein or collagen), or a combination thereof.


Reference is still made to FIGS. 1A-B, and is additionally made to FIG. 2, which is a schematic illustration of stent-graft system 10 viewed from distal end 14, in accordance with an application of the present invention. Graft members 24 circumscribe respective circumferential arcs 40 of respective stent members 22. Circumferential arcs 40 have respective extents that are less than entire circumferences of respective stent members 22 at least partially along respective axial lengths of stent members 22, when stent-grafts 20 are in their respective radially-expanded states. In the configuration shown in FIGS. 1A-B and 2, graft member 24A circumscribes circumferential arc 40A of stent member 22A, and graft member 24B circumscribes circumferential arc 40B of stent member 22B.


As shown in FIGS. 1B and 2, graft members 24 collectively cover (either inside and/or outside) an entire circumference of body portion 16 along entire axial length L of body portion 16, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. As a result, graft members 24 collectively define a fluid flow guide along entire axial length L of body portion 16, in order to define a fluid flow path through the body portion.


Typically, graft members 24 are securely fixed to stent members 22, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along at least 80% of the respective axial lengths of stent members 22, such as along at least 90%, or the entire respective axial lengths, of the stent members, when the stent-grafts are in their radially-expanded states. As a result, when the graft members are radially-compressed for delivery, the crossing profiles of the graft members are less than they would be if the graft members extended around the entire circumferences of the stent members.


For some applications, such as in which stent-graft system 10 comprises exactly two stent-grafts 20, circumferential arcs 40 have respective arc extents, at least one of which is between 1.1π (pi) and 1.4π (pi) radians. Optionally, each (i.e., all) of the respective arc extents is between 1.1π (pi) and 1.4π (pi) radians. For some applications, such as in which stent-graft system 10 comprises exactly three stent-grafts 20, circumferential arcs 40 have respective arc extents, at least one of which is between 0.75π (pi) and 1.1π (pi) radians. Optionally, each (i.e., all) of the respective arc extents is between 0.75π (pi) and 1.1π (pi) radians. For some applications, such as in which stent-graft system 10 comprises exactly four stent-grafts 20, circumferential arcs 40 have respective arc extents, at least one of which is between 0.6π (pi) and 0.75π (pi) radians. Optionally, each (i.e., all) of the respective arc extents is between 0.6π (pi) and 0.75π (pi) radians.


Typically, in order to provide good circumferential sealing between circumferentially-adjacent stent-grafts 20, pairs of circumferentially-adjacent graft members 22 have respective circumferential overlaps 42 having respective arc extents, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. Typically, each of the arc extents is at least 0.05π (pi) radians, such as at least 0.1π (pi) radians.


For some applications, circumferential arcs 40 have respective arc extents, a sum of which is greater than 2.2π (pi) radians, such as at least 2.6π (pi) radians, when (a) stent-grafts 20 are nested within one another along entire axial length L of the body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. Optionally, the sum is equal at least (a) 2π (pi) plus (b) a product of (i) a number of stent-grafts 20 and (ii) 0.1π (pi) radians.


For some applications, such as shown in FIGS. 1A-B and 2, circumferential arcs 40 have respective arc angular centers 50, which are positioned at respective substantially constant circumferential locations along the entire axial length of body portion 16, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. In other words, the circumferential centers of graft members 24 do not vary along the length of the body portion, for example, do not form a helical shape around the body portion.


Alternatively or additionally, for some applications, circumferential arcs 40 have respective arc extents, which are generally constant along entire axial length L of the body portion 16, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. Alternatively, the arc extents vary along at least a portion (e.g., the entire) axial length L of body portion 16.


Reference is now made to FIGS. 3A-B, which are schematic illustrations of another configuration of multi-component endovascular stent-graft system 10, in accordance with an application of the present invention. FIGS. 3A and 3B show the stent-graft system disassembled and assembled, respectively. This configuration is generally similar to the configuration described hereinabove with reference to FIGS. 1A-B and 2, except as follows. In this configuration, respective arc angular centers 50 of circumferential arcs 40 are positioned at respective circumferential locations that vary along at least a portion of axial length L of body portion 16, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. For example, as shown in FIGS. 3A-B, arc angular centers 50 may form a helical shape around body portion 16 (arc angular center 50A of circumferential arc 40A of stent member 22 is labeled in FIG. 3B). Optionally, the respective circumferential locations vary along the entire axial length of body portion 16.


Alternatively or additionally, for some applications, circumferential arcs 40 have respective arc extents, which are generally constant along entire axial length L of the body portion 16, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. Alternatively, the arc extents vary along at least a portion (e.g., the entire) axial length L of body portion 16.


Reference is now made to FIGS. 4A-F, which are schematic illustrations of an exemplary method of deploying multi-component endovascular stent-graft system 10 in the vicinity of an supra-renal abdominal aortic aneurysm 60 of an abdominal aorta 62, using an endovascular stent-graft delivery tool 70, in accordance with an application of the present invention. As shown in FIG. 4A, delivery tool 70 typically comprises a delivery catheter 72, a distal tip 74, and a guidewire 76. During an implementation procedure, a first one of stent-grafts 20 (e.g., stent-graft 20A) is transvascularly (typically percutaneously) introduced into aorta 62 via one of the iliac arteries, while stent-graft 20A is positioned in delivery catheter 72, restrained in its radially-compressed state by the catheter. In this exemplary deployment, delivery catheter 72 and distal tip 74 are advanced over guidewire 76 until the distal tip is positioned slightly below aortic arch 82, and the lower end of the stent-graft is positioned above renal arteries 80.



FIG. 4A shows stent-graft 20A in an early stage of release from delivery catheter 72, and FIG. 4B shows stent-graft 20A in its fully deployed, radially-expanded state, after delivery catheter 72 has been withdrawn.


As shown in FIG. 4C, a second one of stent-grafts 20 (e.g., stent-graft 20B) is positioned in a delivery catheter (either the same delivery catheter 72 used to deploy the first stent-graft, or an additional delivery catheter), restrained in the stent-graft's radially-compressed state by the catheter. Delivery catheter 72, distal tip 74, and guidewire 76 are advanced through the previously-deployed first stent-graft (stent-graft 20A), until stent-graft 20B is positioned at least partially (e.g., entirely) within stent-graft 20A, generally axially aligned with stent-graft 20A.


Before it is deployed from delivery catheter 72, stent-graft 20B is properly rotationally aligned with previously-deployed stent-graft 20A, such that graft members 24A and 24B (and the other remaining stent-grafts 20, if any, as described below) will together form a circumferentially-complete fluid flow guide upon full deployment of stent-graft 20B (and the other remaining stent-grafts 20, if any, as described below). FIG. 4D shows stent-graft 20B in an early stage of release from delivery catheter 72.



FIG. 4E shows stent-graft 20B in its fully deployed radially-expanded state, after the catheter has been withdrawn from the stent-graft. As can be seen, stent-graft 20B is nested within stent-graft 20A, and stent-graft system 10 has been assembled in situ to form a circumferentially complete fluid flow guide comprising first and second stent-grafts 20A and 20B. FIG. 4F shows the stent-graft system 10 fully implanted upon the withdrawal of delivery tool 70 and completion of the implantation procedure.


For configurations in which stent-graft system 10 comprises more than two stent-grafts 20, the procedure described above for deploying stent-grafts 20A and 20B is repeated for the additional stent-grafts, until the stent-grafts are all deployed to together form stent-graft system 10. Each of the subsequently-deployed stent-grafts is positioned at least partially within all of the already-deployed stent-grafts.


Reference is again made to FIG. 1. For some applications, each of stent-grafts 20 further comprises one or more radiopaque markers 90. The radiopaque markers may help the surgeon properly axially and/or rotationally align the stent-grafts with one another, such as described hereinabove with reference to FIG. 4D. For some applications, the radiopaque markers are disposed near edges of the graft members.


Reference is made to FIG. 5, which is a schematic illustration of another configuration of stent-graft system 10, in accordance with an application of the present invention. In this configuration, stent-graft system 10 is shaped so as to define a side-facing fenestration 92, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. For some applications, the side-facing fenestration is generally elliptical, such as generally circular. For some applications, a perimeter of the fenestration is between 10% and 50% of a perimeter of stent-graft system 10 adjacent the fenestration. This fenestrated configuration may be used in combination with any of the configurations described herein.


Reference is made to FIG. 6, which is a schematic illustration of yet another configuration of stent-graft system 10, in accordance with an application of the present invention. This configuration may be used in combination with any of the configurations described herein. In this configuration, stent-graft system 10 further comprises a plurality of outwardly protruding fixation elements 94. For example, fixation elements 94 may be positioned at proximal end 12 of stent-graft system 10, as shown; alternatively or additionally, fixation elements 94 may be positioned at distal end 14 of stent-graft system 10 (not shown). For some applications, fixation elements 94 comprise barbs 96. It is noted that, by way of example, fixation elements 94 shown in FIG. 6 are positioned proximally beyond body portion 16, and thus are not included in axial length L; thus, in this configuration, body portion 16 extends along only part of the length of stent-graft system 10. For some applications, all of stent-grafts 20 comprise the fixation elements, while for other applications, only a portion of the stent-grafts, such as exactly one of the stent-grafts, comprise the fixation elements. For some applications, fixation elements (e.g., barbs) are configured as shown in FIGS. 1, 2, 3, 5A-B, 7A, 7B, 7C, 9A-D, 10A, 10B, 13, 15A-C, 16, 17, 18, 19, 20, and/or 20A-B of the above-mentioned '208 publication, mutatis mutandis.


Stent-graft system 10 may be deployed alone, or as a component of a larger stent-graft system comprising additional stent-grafts, for example as described with reference to FIGS. 4E and/or 21B of the '208 publication, mutatis mutandis, or in PCT Publication WO 08/107885, mutatis mutandis, which is incorporated herein by reference. For some applications, stent-graft system 10 defines a single lumen, while for other applications, the stent-graft system 10 defines a plurality of lumen, e.g., is bifurcated, such as described with reference to FIG. 3 of the above-mentioned '208 publication, mutatis mutandis.


Although the endovascular stent-graft system is generally described herein as being deployed via an iliac artery and the aorto-iliac bifurcation, for some applications, the prostheses are instead deployed via a subclavian artery. Furthermore, although the endovascular stent-graft system is generally described herein as being deployed in the aorta, the system may also be deployed in another blood vessel, such as another artery, e.g., an aneurysmatic artery, such as an aneurysmatic iliac artery.


The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein:

    • PCT Application PCT/IL2008/000287, filed Mar. 5, 2008, which published as PCT Publication WO 2008/107885 to Shalev et al., and U.S. application Ser. No. 12/529,936 in the national stage thereof, which published as US Patent Application Publication 2010/0063575 to Shalev et al.
    • U.S. Provisional Application 60/892,885, filed Mar. 5, 2007
    • U.S. Provisional Application 60/991,726, filed Dec. 2, 2007
    • U.S. Provisional Application 61/219,758, filed Jun. 23, 2009
    • U.S. Provisional Application 61/221,074, filed Jun. 28, 2009
    • PCT Application PCT/IB2010/052861, filed Jun. 23, 2010, which published as PCT Publication WO 2010/150208
    • PCT Application PCT/IL2010/000564, filed Jul. 14, 2010, which published as PCT Publication WO 2011/007354
    • PCT Application PCT/IL2010/000917, filed Nov. 4, 2010, which published as PCT Publication WO 2011/055364
    • PCT Application PCT/IL2010/000999, filed Nov. 30, 2010, which published as PCT Publication WO 2011/064782
    • PCT Application PCT/IL2010/001018, filed Dec. 2, 2010, which published as PCT Publication WO 2011/067764
    • PCT Application PCT/IL2010/001037, filed Dec. 8, 2010, which published as PCT Publication WO 2011/070576
    • PCT Application PCT/IL2011/000135, filed Feb. 8, 2011, which published as PCT Publication WO 2011/095979
    • US Application 13/031,871, filed Feb. 22, 2011, which published as US Patent Application Publication 2011/0208289
    • U.S. Provisional Application 61/496,613, filed Jun. 14, 2011


It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims
  • 1. Apparatus comprising a multi-component endovascular stent-graft system, which has proximal and distal ends, and a body portion disposed along at least a part of the stent-graft system longitudinally between the proximal and distal ends, which body portion has an axial length and comprises a plurality of stent-grafts, which (a) are configured to assume respective radially-compressed states for transluminal delivery, and respective radially-expanded states for intraluminal fixation, and (b) comprise: respective stent members, which are shaped, when the stent-grafts are in their respective radially-expanded states, so as to define respective tubes, each of which is circumferentially-complete at least one longitudinal location therealong; andrespective graft members, which respectively comprise one or more biologically-compatible substantially blood-impervious flexible sheets, and which are securely fixed to the stent members, respectively, such that the graft members circumscribe respective circumferential arcs of the respective stent members, which circumferential arcs have respective extents that are less than entire circumferences of the respective stent members at least partially along respective axial lengths of the stent members, when the stent-grafts are in their respective radially-expanded stateswherein the graft members collectively cover an entire circumference of the body portion and define a circumferentially-closed volume along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
  • 2. The apparatus according to claim 1, wherein the graft members are securely fixed to the stent members, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along at least 80% of the respective axial lengths of the stent members, when the stent-grafts are in their radially-expanded states.
  • 3. The apparatus according to claim 2, wherein the graft members are securely fixed to the stent members, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along the entire respective axial lengths of the stent members, when the stent-grafts are in their radially-expanded states.
  • 4. The apparatus according to claim 1, wherein at least one of the respective arc extents is between 1.1π (pi) and 1.4π (pi) radians.
  • 5. The apparatus according to claim 1, wherein at least one of the respective arc extents is between 0.75π (pi) and 1.1π(pi) radians.
  • 6. The apparatus according to claim 1, wherein at least one of the respective arc extents is between 0.6π (pi) and 0.75π (pi) radians.
  • 7. The apparatus according to claim 1, wherein pairs of circumferentially-adjacent graft members have respective circumferential overlaps having respective arc extents, each of which is at least 0.05π (pi) radians, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
  • 8. The apparatus according to claim 7, wherein each of the overlaps is at least 0.1π (pi) radians.
  • 9. The apparatus according to claim 7, wherein a sum of the respective arc extents is greater than 2.2π (pi) radians, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
  • 10. The apparatus according to claim 9, wherein the sum is equal to at least 2.6π (pi) radians.
  • 11. The apparatus according to claim 9, wherein the sum is equal at least (a) 2π (pi) plus (b) a product of (i) a number of the stent-grafts and (ii) 0.1π (pi) radians.
  • 12. The apparatus according to claim 1, wherein the circumferential arcs have respective arc angular centers, which are positioned at respective circumferential locations that vary along at least a portion of the axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
  • 13. The apparatus according to claim 1, wherein the stent-graft system is shaped so as to define a side-facing fenestration, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
  • 14. The apparatus according to claim 12, wherein the respective circumferential locations vary along the entire axial length of the body portion when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
  • 15. The apparatus according to claim 12, wherein the respective arc extents are generally constant along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
  • 16. The apparatus according to claim 13, wherein the side-facing fenestration is generally circular.
  • 17. The apparatus according to claim 16, wherein a perimeter of the fenestration is between 10% and 50% of a perimeter of the stent-graft system adjacent the fenestration.
  • 18. A method comprising: (i) providing a multi-component endovascular stent-graft system, which has proximal and distal ends, and a body portion disposed along at least a part of the stent-graft system longitudinally between the proximal and distal ends, which body portion has an axial length and comprises a plurality of stent-grafts, which (a) are configured to assume respective radially-compressed states for transluminal delivery, and respective radially-expanded states for intraluminal fixation, and (b) include (x) respective stent members, which are shaped, when the stent-grafts are in their respective radially-expanded states, so as to define respective tubes, each of which is circumferentially-complete at least one longitudinal location therealong, and (y) respective graft members, which respectively comprise one or more biologically-compatible substantially blood-impervious flexible sheets, and which are securely fixed to the stent members, respectively, such that the graft members circumscribe respective circumferential arcs of the respective stent members, which circumferential arcs have respective extents that are less than entire circumferences of the respective stent members at least partially along respective axial lengths of the stent members, when the stent-grafts are in their respective radially-expanded states;(ii) transvascularly introducing a first one of the stent-grafts into a blood vessel of a human subject, while the stent-graft is restrained in its radially-compressed state;(iii) thereafter, deploying the first stent-graft in the blood vessel so that the first stent-graft assumes its radially-expanded state;(iv) thereafter, introducing another one of the stent-grafts into the blood vessel and at least partially into the first stent-graft and any of the other stent-grafts already deployed, while the another stent-graft is restrained in its radially-compressed state;(v) thereafter, axially and rotationally orienting the another stent-graft with the first stent-graft and any of the other stent-grafts already deployed, and deploying the another stent-graft in the blood vessel so that the another stent-graft assumes its radially-expanded state; and(vi) thereafter, repeating steps (iv) and (v) until all of the stent-grafts have been deployed in the blood vesselwherein deploying the stent-grafts comprises deploying the stent-grafts such that the graft members collectively cover an entire circumference of the body portion and define a circumferentially-closed volume along the entire axial length of the body portion.
  • 19. The method according to claim 18, wherein deploying the stent-grafts comprises deploying the stent-grafts such that pairs of circumferentially-adjacent graft members have respective circumferential overlaps having respective arc extents, each of which is at least 0.05π (pi) radians.
  • 20. The method according to claim 19, wherein each of the overlaps is at least 0.1π (pi) radians.
  • 21. The method according to claim 18, wherein providing the stent-graft system comprises providing the stent-graft system in which each of the tubes respectively defined by the stent members is circumferentially-complete along at least three longitudinal locations thereof.
  • 22. The method according to claim 18, wherein the blood vessel is an aorta, and wherein deploying the stent-grafts comprises deploying the stent-grafts in the aorta.
  • 23. The method according to claim 22, further comprising identifying the subject as suffering from an aortic aneurysm, and wherein deploying the stent-grafts comprises deploying the stent-grafts responsively to the identifying.
  • 24. The apparatus according to claim 1, wherein the circumferential arcs have respective arc angular centers, which are positioned at respective substantially constant circumferential locations along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
  • 25. The apparatus according to claim 1, wherein the respective arc extents vary along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
  • 26. The apparatus according to claim 1, wherein the body portion is disposed along only part of the stent-graft system.
  • 27. The apparatus according to claim 1, wherein the stent-graft system further comprises a plurality of outwardly protruding fixation elements.
  • 28. The apparatus according to claim 1, wherein each of the tubes respectively defined by the stent members is circumferentially-complete along at least three longitudinal locations thereof.
  • 29. The apparatus according to claim 1, further comprising a plurality of delivery catheters, in which the stent-grafts are respectively initially positioned in their radially-compressed states.
  • 30. The method according to claim 16, wherein providing the stent-graft system comprises providing the stent-graft system in which the graft members are securely fixed to the stent members, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along at least 80% of the respective axial lengths of the stent members, when the stent-grafts are in their radially-expanded states.
  • 31. The method according to claim 30, wherein providing the stent-graft system comprises providing the stent-graft system in which the graft members are securely fixed to the stent members, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along the entire respective axial lengths of the stent members, when the stent-grafts are in their radially-expanded states.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims priority from U.S. patent application Ser. No. 61/499,195, filed Jun. 21, 2011, which is assigned to the assignee of the present application and is incorporated herein by reference.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/IL2012/000241 6/19/2012 WO 00 2/8/2013
Publishing Document Publishing Date Country Kind
WO2012/176187 12/27/2012 WO A
US Referenced Citations (288)
Number Name Date Kind
4355426 MacGregor Oct 1982 A
4505767 Quin Mar 1985 A
4562596 Kornberg Jan 1986 A
4577631 Kreamer Mar 1986 A
4617932 Kornberg Oct 1986 A
4665906 Jervis May 1987 A
4739762 Palmaz Apr 1988 A
4787899 Lazarus Nov 1988 A
4878906 Lindemann et al. Nov 1989 A
4886062 Wiktor Dec 1989 A
4938740 Melbin Jul 1990 A
4969458 Wiktor Nov 1990 A
5042707 Taheri Aug 1991 A
5064435 Porter Nov 1991 A
5104404 Wolff Apr 1992 A
5122136 Guglielmi et al. Jun 1992 A
5133732 Wiktor Jul 1992 A
5234448 Wholey et al. Aug 1993 A
5486183 Middleman et al. Jan 1996 A
5507769 Marin et al. Apr 1996 A
5509923 Middleman et al. Apr 1996 A
5522880 Barone et al. Jun 1996 A
5527322 Klein et al. Jun 1996 A
5549662 Fordenbacher Aug 1996 A
5554181 Das Sep 1996 A
5556413 Lam Sep 1996 A
5562724 Vorwerk et al. Oct 1996 A
5607445 Summers Mar 1997 A
5613974 Andreas et al. Mar 1997 A
5632746 Middleman et al. May 1997 A
5632763 Glastra May 1997 A
5632772 Alcime et al. May 1997 A
5639278 Dereume et al. Jun 1997 A
5643340 Nunokawa Jul 1997 A
5653743 Martin Aug 1997 A
5676696 Marcade Oct 1997 A
5676697 McDonald Oct 1997 A
5728134 Barak Mar 1998 A
5749879 Middleman et al. May 1998 A
5755770 Ravenscroft May 1998 A
5755771 Penn et al. May 1998 A
5755777 Chuter May 1998 A
5755781 Jayaraman May 1998 A
5769882 Fogarty et al. Jun 1998 A
5769884 Solovay Jun 1998 A
5782903 Wiktor Jul 1998 A
5782906 Marshall et al. Jul 1998 A
5824040 Cox et al. Oct 1998 A
5827321 Roubin et al. Oct 1998 A
5843170 Ahn Dec 1998 A
5855600 Alt Jan 1999 A
5860991 Klein et al. Jan 1999 A
5876432 Lau et al. Mar 1999 A
5906641 Thompson et al. May 1999 A
5921994 Andreas et al. Jul 1999 A
5980552 Pinchasik et al. Nov 1999 A
6015431 Thornton et al. Jan 2000 A
6016810 Ravenscroft Jan 2000 A
6030414 Taheri Feb 2000 A
6033435 Penn et al. Mar 2000 A
6036725 Avellanet Mar 2000 A
6059824 Taheri May 2000 A
6099497 Adams et al. Aug 2000 A
6117145 Wood et al. Sep 2000 A
6132457 Chobotov Oct 2000 A
6156064 Chouinard Dec 2000 A
6200339 Leschinsky et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6270524 Kim Aug 2001 B1
6283991 Cox et al. Sep 2001 B1
6290720 Khosravi et al. Sep 2001 B1
6312458 Golds Nov 2001 B1
6325823 Horzewski et al. Dec 2001 B1
6344056 Dehdashtian Feb 2002 B1
6428565 Wisselink Aug 2002 B1
6506211 Skubitz et al. Jan 2003 B1
6520988 Colombo et al. Feb 2003 B1
6613078 Barone Sep 2003 B1
6635083 Cheng et al. Oct 2003 B1
6652567 Deaton Nov 2003 B1
6656214 Fogarty et al. Dec 2003 B1
6692520 Gambale et al. Feb 2004 B1
6695833 Frantzen Feb 2004 B1
6743195 Zucker Jun 2004 B2
6752826 Holloway et al. Jun 2004 B2
6776794 Hong et al. Aug 2004 B1
6808534 Escano Oct 2004 B1
6814749 Cox et al. Nov 2004 B2
6814752 Chuter Nov 2004 B1
6824560 Pelton Nov 2004 B2
6846321 Zucker Jan 2005 B2
6907285 Denker et al. Jun 2005 B2
6908477 McGuckin, Jr. et al. Jun 2005 B2
6929660 Ainsworth et al. Aug 2005 B1
6942691 Chuter Sep 2005 B1
6964679 Marcade et al. Nov 2005 B1
6986774 Middleman et al. Jan 2006 B2
7008441 Zucker Mar 2006 B2
7044962 Elliott May 2006 B2
7105020 Greenberg et al. Sep 2006 B2
7112217 Kugler et al. Sep 2006 B1
7115127 Lindenbaum et al. Oct 2006 B2
7144421 Carpenter et al. Dec 2006 B2
7198638 Dong Apr 2007 B2
7201772 Schwammenthal Apr 2007 B2
7223266 Lindenbaum et al. May 2007 B2
7279003 Berra et al. Oct 2007 B2
7294145 Ward Nov 2007 B2
7306623 Watson Dec 2007 B2
7341598 Davidson et al. Mar 2008 B2
7407509 Greenberg et al. Aug 2008 B2
7429269 Schwammenthal Sep 2008 B2
7438721 Doig Oct 2008 B2
7442204 Schwammenthal Oct 2008 B2
7473272 Pryor Jan 2009 B2
7491231 Nazzaro Feb 2009 B2
7537609 Davidson et al. May 2009 B2
7540881 Meyer et al. Jun 2009 B2
7544160 Gross Jun 2009 B2
7637939 Tischler Dec 2009 B2
7662161 Briganti et al. Feb 2010 B2
7662168 McGuckin, Jr. et al. Feb 2010 B2
7678141 Greenan et al. Mar 2010 B2
7722626 Middleman et al. May 2010 B2
7731732 Ken Jun 2010 B2
7803178 Whirley et al. Sep 2010 B2
7806923 Moloney Oct 2010 B2
7815673 Bloom et al. Oct 2010 B2
7887575 Kujawski Feb 2011 B2
7955374 Erickson et al. Jun 2011 B2
7959662 Erbel et al. Jun 2011 B2
8066755 Zacharias et al. Nov 2011 B2
8080053 Satasiya et al. Dec 2011 B2
8172892 Chuter et al. May 2012 B2
20010004705 Killion et al. Jun 2001 A1
20010014823 Resseman et al. Aug 2001 A1
20010034550 Buirge et al. Oct 2001 A1
20010044651 Steinke et al. Nov 2001 A1
20010044652 Moore Nov 2001 A1
20010047198 Drasler et al. Nov 2001 A1
20010053930 Kugler et al. Dec 2001 A1
20020040236 Lau et al. Apr 2002 A1
20020099438 Furst Jul 2002 A1
20020099441 Dehdashtian Jul 2002 A1
20020107564 Cox et al. Aug 2002 A1
20020123791 Harrison Sep 2002 A1
20020156495 Brenneman et al. Oct 2002 A1
20030040791 Oktay Feb 2003 A1
20030074055 Haverkost Apr 2003 A1
20030093145 Lawrence-Brown et al. May 2003 A1
20030130720 DePalma et al. Jul 2003 A1
20030144725 Lombardi Jul 2003 A1
20030153968 Geis et al. Aug 2003 A1
20030191523 Hojeibane Oct 2003 A1
20030199967 Hartley et al. Oct 2003 A1
20030199968 Ainsworth et al. Oct 2003 A1
20030212449 Cox Nov 2003 A1
20030236567 Elliot Dec 2003 A1
20040015227 Vardi et al. Jan 2004 A1
20040015229 Fulkerson et al. Jan 2004 A1
20040098091 Erbel et al. May 2004 A1
20040106972 Deaton Jun 2004 A1
20040106978 Greenberg et al. Jun 2004 A1
20040133266 Clerc et al. Jul 2004 A1
20040171978 Shalaby Sep 2004 A1
20040181149 Langlotz et al. Sep 2004 A1
20040215327 Doig et al. Oct 2004 A1
20050033406 Barnhart et al. Feb 2005 A1
20050049678 Cocks et al. Mar 2005 A1
20050065545 Wallace Mar 2005 A1
20050085900 Case et al. Apr 2005 A1
20050102018 Carpenter et al. May 2005 A1
20050102021 Osborne May 2005 A1
20050131517 Hartley et al. Jun 2005 A1
20050149166 Schaeffer et al. Jul 2005 A1
20050154448 Cully et al. Jul 2005 A1
20050171598 Schaeffer Aug 2005 A1
20050203606 VanCamp Sep 2005 A1
20050222667 Hunt Oct 2005 A1
20050222668 Schaeffer et al. Oct 2005 A1
20050222669 Purdy Oct 2005 A1
20050266042 Tseng Dec 2005 A1
20050283188 Loshakove et al. Dec 2005 A1
20060015170 Jones et al. Jan 2006 A1
20060052799 Middleman et al. Mar 2006 A1
20060069426 Weinberger Mar 2006 A1
20060100684 Elliott May 2006 A1
20060106406 Weinberger May 2006 A1
20060149360 Schwammenthal Jul 2006 A1
20060155358 LaDuca et al. Jul 2006 A1
20060155366 LaDuca et al. Jul 2006 A1
20060167476 Burdulis, Jr. et al. Jul 2006 A1
20060173530 Das Aug 2006 A1
20060193892 Furst et al. Aug 2006 A1
20060229709 Morris et al. Oct 2006 A1
20060241740 Vardi et al. Oct 2006 A1
20060281966 Peacock, III Dec 2006 A1
20070021822 Boatman Jan 2007 A1
20070043425 Hartley et al. Feb 2007 A1
20070050011 Klein et al. Mar 2007 A1
20070055350 Erickson et al. Mar 2007 A1
20070055358 Krolik et al. Mar 2007 A1
20070060989 Deem et al. Mar 2007 A1
20070061002 Paul, Jr. et al. Mar 2007 A1
20070073373 Bonsignore Mar 2007 A1
20070088425 Schaeffer Apr 2007 A1
20070112344 Keilman May 2007 A1
20070135677 Miller et al. Jun 2007 A1
20070142896 Anderson et al. Jun 2007 A1
20070150051 Menardiere et al. Jun 2007 A1
20070156167 Connors et al. Jul 2007 A1
20070167898 Peters et al. Jul 2007 A1
20070167955 Menardiere et al. Jul 2007 A1
20070168018 Amplatz et al. Jul 2007 A1
20070179598 Duerig Aug 2007 A1
20070185565 Schwammenthal et al. Aug 2007 A1
20070208410 Berra et al. Sep 2007 A1
20070213805 Schaeffer et al. Sep 2007 A1
20070213807 Roubin et al. Sep 2007 A1
20070219610 Israel Sep 2007 A1
20070219627 Chu Sep 2007 A1
20070233229 Berra et al. Oct 2007 A1
20070237973 Purdy et al. Oct 2007 A1
20070244542 Greenan et al. Oct 2007 A1
20070244543 Mitchell Oct 2007 A1
20070244547 Greenan Oct 2007 A1
20070250154 Greenberg et al. Oct 2007 A1
20070255388 Rudakov et al. Nov 2007 A1
20080002871 Gunzert-Marx et al. Jan 2008 A1
20080015673 Chuter Jan 2008 A1
20080058918 Watson Mar 2008 A1
20080097578 Erickson et al. Apr 2008 A1
20080109066 Quinn May 2008 A1
20080114444 Yu May 2008 A1
20080114445 Melsheimer et al. May 2008 A1
20080147173 McIff et al. Jun 2008 A1
20080167704 Wright et al. Jul 2008 A1
20080195190 Bland et al. Aug 2008 A1
20080195191 Luo et al. Aug 2008 A1
20080215134 Lawrence/Brown Sep 2008 A1
20080249598 Sherry Oct 2008 A1
20080269789 Eli Oct 2008 A1
20080275540 Wen Nov 2008 A1
20080275542 LaDuca et al. Nov 2008 A1
20080288044 Osborne Nov 2008 A1
20080300665 Lootz et al. Dec 2008 A1
20080319528 Yribarren et al. Dec 2008 A1
20090012597 Doig et al. Jan 2009 A1
20090012602 Quadri Jan 2009 A1
20090030502 Sun et al. Jan 2009 A1
20090048663 Greenberg Feb 2009 A1
20090054967 Das Feb 2009 A1
20090062899 Dang et al. Mar 2009 A1
20090069882 Venturelli et al. Mar 2009 A1
20090082841 Zacharias et al. Mar 2009 A1
20090099648 Yu Apr 2009 A1
20090099649 Chobotov et al. Apr 2009 A1
20090099650 Bolduc et al. Apr 2009 A1
20090105809 Lee et al. Apr 2009 A1
20090112233 Xiao Apr 2009 A1
20090125096 Chu et al. May 2009 A1
20090138067 Pinchuk et al. May 2009 A1
20090149877 Hanson et al. Jun 2009 A1
20090227997 Wang et al. Sep 2009 A1
20090240316 Bruszewski Sep 2009 A1
20090248134 Dierking et al. Oct 2009 A1
20090254170 Hartley et al. Oct 2009 A1
20090259290 Bruszewski et al. Oct 2009 A1
20090287145 Cragg et al. Nov 2009 A1
20100004728 Rao et al. Jan 2010 A1
20100029608 Finley et al. Feb 2010 A1
20100063575 Shalev Mar 2010 A1
20100070019 Shalev Mar 2010 A1
20100082091 Berez et al. Apr 2010 A1
20100161026 Brocker et al. Jun 2010 A1
20100211159 Schmid et al. Aug 2010 A1
20100256725 Rasmussen Oct 2010 A1
20100292774 Shalev Nov 2010 A1
20100318171 Porter et al. Dec 2010 A1
20110093002 Rucker et al. Apr 2011 A1
20110125251 Cottone et al. May 2011 A1
20110208289 Shalev Aug 2011 A1
20110208296 Duffy et al. Aug 2011 A1
20110208297 Tuval Aug 2011 A1
20110208298 Tuval Aug 2011 A1
20110218607 Arbefeuille et al. Sep 2011 A1
20110264184 Heltai Oct 2011 A1
20120310324 Benary et al. Dec 2012 A1
Foreign Referenced Citations (51)
Number Date Country
2 497 704 Mar 2004 CA
201058061 May 2008 CN
1177780 Feb 2002 EP
1325716 Jul 2003 EP
2 298 248 Mar 2011 EP
2002-253682 Sep 2002 JP
2004017868 Mar 2004 WO
2005002466 Jan 2005 WO
2005037138 Apr 2005 WO
2005041781 May 2005 WO
2005041783 May 2005 WO
2006007389 Jan 2006 WO
2006028925 Mar 2006 WO
2006070372 Jul 2006 WO
2007084547 Jul 2007 WO
2007144782 Dec 2007 WO
2008008291 Jan 2008 WO
2008035337 Mar 2008 WO
2008042266 Apr 2008 WO
2008047092 Apr 2008 WO
2008047354 Apr 2008 WO
2008053469 May 2008 WO
2008107885 Sep 2008 WO
2008140796 Nov 2008 WO
2009078010 Jun 2009 WO
2009116041 Sep 2009 WO
2009116042 Sep 2009 WO
2009118733 Oct 2009 WO
2010024869 Mar 2010 WO
2010024879 Mar 2010 WO
2010031060 Mar 2010 WO
2010045238 Apr 2010 WO
2010062355 Jun 2010 WO
2010088776 Aug 2010 WO
2010128162 Nov 2010 WO
2010150208 Dec 2010 WO
2011004374 Jan 2011 WO
2011007354 Jan 2011 WO
2011055364 May 2011 WO
2011064782 Jun 2011 WO
2011067764 Jun 2011 WO
2011070576 Jun 2011 WO
2011080738 Jul 2011 WO
2011095979 Aug 2011 WO
2011106532 Sep 2011 WO
2011106533 Sep 2011 WO
2011106544 Sep 2011 WO
2012049679 Apr 2012 WO
2012104842 Aug 2012 WO
2012111006 Aug 2012 WO
2012117395 Sep 2012 WO
Non-Patent Literature Citations (34)
Entry
“E-vita® open plus” product brochure (JOTEC GmbH, Hechingen, Germany) (2010).
An English Translation of an Office Action dated Aug. 25, 2011, which issued during the prosecution of Chinese Patent Application No. 200880014919.9.
Fonseca A et al., “Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions,” J Invasive Cardiol 20(1):21-7 (Jan. 2008).
An International Search Report and a Written Opinion both dated Sep. 24, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000060.
Khlif H et al., “Contribution to the Improvement of Textile Vascular Prostheses Crimping,” Trends in Applied Sciences Research 6(9):1019-1027 (2011).
An International Search Report and a Written Opinion both dated Jul. 13, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000083.
An International Search Report and a Written Opinion both dated Jul. 17, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000095.
An International Search Report and a Written Opinion both dated Aug. 31, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000148.
An International Search Report and a Written Opinion both dated Sep. 6, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000190.
An International Search Report and a Written Opinion both dated Jun. 19, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000241.
An International Search Report and a Written Opinion both dated Nov. 27, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000300.
An International Search Report and a Written Opinion both dated Feb. 4, 2011, which issued during the prosecution of Applicant's PCT/IB2010/052861.
An International Search Report and a Written Opinion both dated Sep. 29, 2008, which issued during the prosecution of Applicant's PCT/IL08/000287.
An International Search Report and a Written Opinion both dated Mar. 11, 2009, which issued during the prosecution of Applicant's PCT/IL2007/001312.
An International Search Report and a Written Opinion both dated Jun. 30, 2009, which issued during the prosecution of Applicant's PCT/IL2008/001621.
An International Search Report and a Written Opinion both dated Nov. 5, 2010, which issued during the prosecution of Applicant's PCTIL2010000549.
An International Search Report and a Written Opinion both dated Dec. 3, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000564.
An International Search Report and a Written Opinion both dated Mar. 10, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000917.
An International Search Report and a Written Opinion both dated Aug. 4, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000999.
An International Search Report and a Written Opinion both dated Mar. 30, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001018.
An International Search Report and a Written Opinion both dated Apr. 18, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001037.
An International Search Report and a Written Opinion both dated May 23, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001087.
An International Search Report and a Written Opinion both dated Jun. 28, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000135.
An International Search Report dated Oct. 4, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000269.
An Office Action dated Apr. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/447,684.
An Office Action dated Nov. 12, 2010, which issued during the prosecution of U.S. Appl. No. 12/447,684.
An Office Action dated Mar. 24, 2011, which issued during the prosecution of U.S. Appl. No. 12/529,936.
An Office Action dated Oct. 28, 2011, which issued during the prosecution of U.S. Appl. No. 12/529,936.
An Office Action dated Jun. 19, 2012, which issued during the prosecution of U.S. Appl. No. 12/808,037.
An Office Action dated Oct. 11, 2012, which issued during the prosecution of U.S. Appl. No. 13/031,871.
European Search Report issued Feb. 24, 2014 in European Patent Application No. 12803376.8.
An Advisory Action dated Feb. 13, 2014, which issued during the prosecution of Applicant's U.S. Appl. No. 13/807,880.
An Office Action dated Feb. 28, 2014, which issued during the prosecution of Applicant's U.S. Appl. No. 13/512,778.
European Office Action issued Dec. 17, 2014 in European Patent Application No. 12803376.8.
Related Publications (1)
Number Date Country
20130204343 A1 Aug 2013 US
Provisional Applications (1)
Number Date Country
61499195 Jun 2011 US